Reckitt Benckiser Group (OTCMKTS:RBGLY) Shares Cross Below 200 Day Moving Average – Time to Sell?

Reckitt Benckiser Group PLC (OTCMKTS:RBGLYGet Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $15.95 and traded as low as $14.11. Reckitt Benckiser Group shares last traded at $14.13, with a volume of 733,330 shares trading hands.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on RBGLY shares. Morgan Stanley downgraded shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 15th. Royal Bank Of Canada cut shares of Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research report on Wednesday, January 14th. Jefferies Financial Group reissued a “hold” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Citigroup began coverage on Reckitt Benckiser Group in a research note on Wednesday, January 14th. They issued a “buy” rating on the stock. Finally, Zacks Research upgraded Reckitt Benckiser Group to a “hold” rating in a research report on Tuesday, March 3rd. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Get Our Latest Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Performance

The company’s 50 day moving average is $16.59 and its 200-day moving average is $15.94. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.37 and a current ratio of 0.56.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Further Reading

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.